UNC-Lineberger Comprehensive Cancer Center: Experimental CAR-M Immunotherapy Shows Promise in Solid Tumors
April 01, 2025
April 01, 2025
CHAPEL HILL, North Carolina, April 1 -- The University of North Carolina Lineberger Comprehensive Cancer Center issued the following news:
* * *
Experimental CAR-M immunotherapy shows promise in solid tumors
An experimental immunotherapy using chimeric antigen receptor macrophages (CAR-M) is safe and helps activate the body's immune system against certain solid cancers, UNC Lineberger researchers and their colleagues report in Nature Medicine.
* * *
Experimental CAR-M immunotherapy shows promise in solid tumors
An experimental immunotherapy using chimeric antigen receptor macrophages (CAR-M) is safe and helps activate the body's immune system against certain solid cancers, UNC Lineberger researchers and their colleagues report in Nature Medicine.